Closer to Universal Newborn Screening for Congenital Cytomegalovirus Infection but Far Away from Antiviral Therapy in All Infected Infants

In this volume of The Journal, 2 studies address the diagnosis and management of infants with congenital cytomegalovirus (cCMV) infection. Lu et al report on a prospective study evaluating the feasibility of incorporating cytomegalovirus (CMV) and genetic screening for common hearing loss mutations into current newborn hearing screening (NBHS) programs in Taiwan.1 Pasternak et al retrospectively describe their experience with antiviral therapy in a small uncontrolled cohort of infants with cCMV infection who have isolated sensorineural hearing loss (SNHL) but otherwise are asymptomatic.

https://ift.tt/2vJnjao